The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
2 天
Medical Device Network on MSNFDA tags Medtronic embolisation device recall as Class IThe US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The recall impacts the Pipeline Vantage devices compatible only with 0.027" inner diameter microcatheters, Medtronic said.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果